Animal Clinical Trials
Clinical research proves Can-C™ Safe and Effective “A new phenomenon of “melting snow” in only a few short weeks…
The testing of various anti-glycation agents over nearly a decade led a Russian research team to the development of n-alpha-acetylcarnosine as a delivery system for the natural eye anti-oxidant of L-carnosine. Once laboratory testing was passed, the next stage began to test the N-acetyl-carnosine Can-C eye-drops in the eyes of animals, (specifically canines and rabbits). These studies produced remarkably fast results in the improvement of clarity, glare sensitivity and overall vision for the animals involved. Furthermore, no serious side effects were noted and the beneficial affects were sustainable. Unsurprisingly, these positive results in animals led to the studies being continued in humans.
Control Study: Thirty dogs, (60 eyes) received topical application of Can-C 1% N-acetylcarnosine eye drop solution twice daily to cataracts.
•Improved visual behaviour of the animals within weeks of treatment.
•Cataract reversal starts from the periphery of the cataract followed by increased transparency of the lens.
•96% of canine eyes treated with N-acetylcarnosine (Can-C) showed notable improvements.
•Dogs with both immature and ripe cataracts showed significant visual improvement.
Current Drug Therapy, 2006, Vol. 1, No. 1 107 – Excerpt from; “TREATMENT OF AGE- RELATED CATARACTS IN CANINES” – Mark Babizhayev MA PhD
“Controlled clinical trials for age-related cataracts in canines and rabbits has been conducted and the efficacy of using N-acetylcarnosine for cataract treatment was established. The striking results in canines and rabbits for both cataract reversal and prevention of lens opacities are clear.”
Dr. Mark Babizhayev MA, PhDSenior Research Investigator – Innovative Vision Products
Many dog owners are now using this product to effectively address their pet’s cataract condition including veterinarians. Results in the Russian clinical trials were quite impressive with canines with no negative side affects. Dr. Babizhayev has also noted that Can-C appears to work even more effectively in canines than in humans. The dosage for animals has not yet been clearly defined so most pet owners are following the same dosage recommendation for humans and are applying 3 to 4 drops per affected eye daily. Remember also that the use of any unapproved drug for your animals should be discussed with your veterinarian. NOTE: Can-C™ is manufactured in a GMP certified, pharmaceutical facility which meets ISO 9001:2000 and ISO 13485:2003 standards for the design/formulation and manufacture of sterile contact lens solution and pharmaceutical solutions.